AIMP2-DX2-IN-1

AIMP2-DX2-IN-1 is a potent and selective small molecule inhibitor of the oncogenic splice variant AIMP2-DX2. It demonstrates promising antitumor activity in preclinical studies, showing efficacy in both in vitro cellular models and in vivo xenograft models of lymphoma, supporting its use as a research tool in oncology.